Cannabis Use Disorder Market Research Report 2025-2035: Pharmaceutical R&D Focus Intensifies on Targeted Therapies – Aelis Farma Advances AEF0117, a Selective CB1 Modulator, in Phase IIb Development
The global cannabis use disorder market is rapidly expanding, driven by increased recognition of cannabis use as a public health issue and the ongoing development of investigational treatments, including cannabinoid receptor antagonists. With no FDA-approved …
Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) — The “Cannabis Use Disorder Market – A Global and Regional Analysis: Focus on Country and Regional Analysis, 2025-2035” report has been added to ResearchAndMa…